Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc monthly Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-25.60 Insider Own0.10% Shs Outstand327.80M Perf Week2.45%
Market Cap52.86B Forward P/E9.53 EPS next Y16.92 Insider Trans0.54% Shs Float327.14M Perf Month-0.40%
Income-8519.10M PEG- EPS next Q4.19 Inst Own90.10% Short Float1.81% Perf Quarter15.58%
Sales15.68B P/S3.37 EPS this Y24.90% Inst Trans2.15% Short Ratio1.20 Perf Half Y18.05%
Book/sh182.05 P/B0.89 EPS next Y1.28% ROA-8.50% Target Price181.76 Perf Year-15.47%
Cash/sh6.02 P/C26.78 EPS next 5Y3.27% ROE-13.20% 52W Range114.27 - 197.00 Perf YTD20.64%
Dividend2.96 P/FCF12.26 EPS past 5Y-36.00% ROI-4.80% 52W High-18.15% Beta1.59
Dividend %1.84% Quick Ratio0.90 Sales past 5Y43.40% Gross Margin85.10% 52W Low41.11% ATR1.96
Employees16900 Current Ratio1.00 Sales Q/Q-0.80% Oper. Margin-54.60% RSI (14)64.98 Volatility1.29% 1.11%
OptionableYes Debt/Eq0.38 EPS Q/Q-285.10% Profit Margin-54.20% Rel Volume0.63 Prev Close159.11
ShortableYes LT Debt/Eq0.33 EarningsAug 06 BMO Payout- Avg Volume4.93M Price161.25
Recom2.60 SMA200.97% SMA504.19% SMA2009.34% Volume3,123,032 Change1.34%
Aug-07-19Downgrade Guggenheim Buy → Neutral
Jul-18-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-16-19Downgrade Bernstein Outperform → Mkt Perform
Jun-11-19Initiated Barclays Underweight $133
May-28-19Initiated Goldman Neutral
Apr-15-19Initiated Jefferies Hold
Mar-20-19Initiated SunTrust Buy $178
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Aug-21-19 04:15PM  Opioid Epidemic: Will Pharmas Scramble To Settle As Landmark Case Looms? Investor's Business Daily
01:38PM  Endo Up on Settlement of a Few Cases Related to Opioid Drugs Zacks
01:11PM  Goldman Warns Hedge Fund Outperformance Holds Crowding Risk Bloomberg
07:15AM  AbbVie Stock Slipped to a New Low, and One Exec Scooped Up Shares Barrons.com
Aug-20-19 11:06AM  Buy AbbVie Stock Because You Cant Ignore How Cheap It Is Barrons.com
09:44AM  Here's Why Allergan is Outperforming Its Industry Of Late Zacks
06:43AM  Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit TheStreet.com
03:23AM  [video]Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report TheStreet.com
Aug-19-19 02:45PM  Obesity Epidemic Leads To A New Problem And It Could Be Worth Billions Investor's Business Daily
Aug-16-19 01:35PM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
Aug-15-19 12:50PM  Seth Klarman's Baupost Boosts Liberty, Reduces eBay GuruFocus.com
Aug-14-19 07:59AM  Correction: Allergan sale Financial Times
12:00AM  Elliott bags Goldmans Barg Financial Times
Aug-13-19 10:59AM  Implied Volatility Surging for Allergan (AGN) Stock Options Zacks
10:48AM  Here's Why Amgen Stock is Outperforming Its Industry Of Late Zacks
09:45AM  Can Value Investors Consider Allergan (AGN) a Worthy Pick? Zacks
01:04AM  JPMorgan Chase set to scoop record fee for Allergan sale Financial Times
Aug-12-19 07:59AM  UPDATE 1-Evolus reports sales of its Botox rival ahead of expectations Reuters
07:01AM  Evolus says launch of its Botox rival ahead of its expectations Reuters
Aug-09-19 09:50AM  Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Zacks
Aug-08-19 08:34AM  Teva (TEVA) Q2 Earnings, Sales Top Estimates, CFO Steps Down Zacks
Aug-07-19 09:32AM  Editas (EDIT) Misses on Q2 Earnings & Sales, Gets New CEO Zacks
Aug-06-19 03:00PM  Allergan Boosts 2019 Guidance While Waiting to be Acquired by AbbVie Motley Fool
01:19PM  Allergan beats second-quarter expectations, boosts full-year guidance MarketWatch
10:19AM  Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up Zacks
10:16AM  Company News For Aug 6, 2019 Zacks
09:58AM  Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand Reuters
09:51AM  Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand Reuters
08:55AM  Allergan (AGN) Surpasses Q2 Earnings and Revenue Estimates Zacks
07:32AM  Allergan Reports Q2 Earnings Beat, Reaffirms Guidance Benzinga
07:26AM  Allergan reports second-quarter earnings beat MarketWatch
07:00AM  Allergan Reports Second Quarter 2019 Financial Results PR Newswire
05:37AM  Allergan Tops Q2 Profit Estimate, Lifts 2019 Revenue Guidance After Abbive Deal TheStreet.com
Aug-05-19 10:10AM  Can Allergan (AGN) Keep the Earnings Surprise Streak Alive? Zacks
10:09AM  Is a Beat in Store for Melinta (MLNT) This Earnings Season? Zacks
09:07AM  Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings? Zacks
Aug-02-19 05:45PM  Allergan (AGN) Gains As Market Dips: What You Should Know Zacks
07:30AM  Allergan to Report Second Quarter 2019 Financial Results PR Newswire
Aug-01-19 09:21AM  Proteostasis (PTI) to Post Q2 Earnings: What's in Store? Zacks
Jul-31-19 10:58AM  Ironwood (IRWD) Q2 Earnings and Revenues Beat Estimates Zacks
08:35AM  Should You Buy Allergan (AGN) Ahead of Earnings? Zacks
05:01AM  Heres How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal InvestorPlace
Jul-30-19 12:58PM  T. Rowe Price Buys Fox, General Electric GuruFocus.com
Jul-29-19 11:08AM  Guardant Health (GH) to Report Q2 Earnings: What's in Store? Zacks
07:30AM  Ashley Tisdale Joins The Allergan 'Women Who Know' Campaign PR Newswire
Jul-26-19 06:23PM  AbbVie Inc (ABBV) Q2 2019 Earnings Call Transcript Motley Fool
11:51AM  AbbVie spotlights Allergan deal, new drugs as Humira sales wane Reuters
11:50AM  What's in the Cards for Amarin (AMRN) This Earnings Season? Zacks
10:15AM  AbbVie does not expect to divest new psoriasis drug Reuters
09:27AM  5 Drug/Biotech Stocks Set to Beat Earnings Estimates in Q2 Zacks
08:52AM  AbbVie Delivers a Win on Earnings and Raises Profit Forecast Barrons.com
Jul-25-19 09:00AM  Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10 GlobeNewswire
07:29AM  What's in the Cards for AcelRx (ACRX) This Earnings Season? Zacks
Jul-24-19 05:48PM  Allergan issues worldwide recall for textured breast implants ABC News Videos
11:26AM  Allergan recalls textured breast implants worldwide Reuters
09:16AM  UPDATE 3-Allergan recalls textured breast implants worldwide Reuters
08:59AM  Allergan issues worldwide recall of Biocell textured implants and tissue expanders MarketWatch
08:55AM  Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders PR Newswire
08:45AM  Allergan recalls textured breast implants across markets Reuters
08:41AM  Should You Buy Allergan (AGN) Ahead of Earnings? Zacks
08:30AM  Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders PR Newswire
Jul-23-19 02:03PM  Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings InvestorPlace
10:18AM  The AbbVie-Allergan Merger Is the Most Positive of the Pharma Deals Barrons.com
Jul-22-19 10:06AM  Can Allergan (AGN) Keep the Earnings Streak Alive in Q2? Zacks
09:55AM  Is a Beat in Store for AbbVie (ABBV) This Earnings Season? Zacks
Jul-21-19 12:10PM  AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout Motley Fool
09:00AM  Better Buy: Pfizer vs. AbbVie Motley Fool
Jul-19-19 04:58PM  The 3 Top Stocks for Dividends Every Calendar Month GuruFocus.com
04:57PM  Is a Beat in the Cards for Bristol-Myers (BMY) Q2 Earnings? Zacks
09:53AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus Zacks
07:30AM  Allergan Declares Third Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire
Jul-18-19 11:00PM  Amgen And Allergan's MVASI (bevacizumab-awwb) And KANJINTI (trastuzumab-anns) Now Available In The United States PR Newswire
06:26PM  Allergan Announces FDA Acceptance of Glaucoma Candidate NDA Zacks
11:11AM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
10:33AM  Allergan (AGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
Jul-17-19 03:04PM  Hagens Berman: Federal Judge Greenlights Class-Action Antitrust Lawsuit Against Allergan Subsidiaries for Loestrin 24, Minastrin and Generics Business Wire
01:12PM  The Top 5 Buys of the T Rowe Price Equity Income Fund GuruFocus.com
07:30AM  U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension PR Newswire
Jul-16-19 05:50PM  Allergan (AGN) Dips More Than Broader Markets: What You Should Know Zacks
04:19PM  Is a Beat in the Cards for Novartis' (NVS) Q2 Earnings? Zacks
04:09PM  AbbVie Buys Allergan for $63 Billion Meredith Videos
09:49AM  Allergan Stock Wont Rise Much More, Analyst Says, in Looking at Deal With AbbVie Barrons.com
09:36AM  Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA Zacks
Jul-14-19 11:10AM  Health companies start reporting earnings next week: Here are 3 things to keep in mind MarketWatch
09:00AM  Is Allergan a Buy? Motley Fool
Jul-12-19 08:24PM  Investor Rights Alert: Halper Sadeh LLP Continues Investigating Whether the Sale of These Companies is Fair to Shareholders; Investors Are Encouraged to Contact the Firm DFRG, RTEC, PCMI, AGN GlobeNewswire
Jul-11-19 07:53AM  J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store? Zacks
Jul-10-19 05:50PM  Allergan (AGN) Gains But Lags Market: What You Should Know Zacks
04:53PM  Longleaf Partners Comments on Allergan GuruFocus.com
01:44PM  Longleaf Partners Fund's 2nd-Quarter Commentary GuruFocus.com
08:14AM  Will Patent Woes Boost Pharma Stock Megamergers Further? Zacks
Jul-09-19 03:55PM  Federal judge blocks Trump Administration's proposal to include wholesale drug prices in TV ads Yahoo Finance Video
09:45AM  Intra-Cellular Therapies' Candidate Fails in Phase III Study Zacks
07:41AM  Allergan Continues to Demonstrate Leadership in Migraine with 29 Presentations at the 2019 American Headache Society Annual Meeting PR Newswire
Jul-08-19 06:03PM  3 Dividend Stocks Retirees Must Have in Their Portfolios GuruFocus.com
09:41AM  AbbVie (ABBV) Shares Down So Far This Year: Here's Why Zacks
Jul-05-19 08:57AM  Editas (EDIT) Focuses on Developing Eye Candidate EDIT-101 Zacks
Jul-04-19 12:35PM  Why AbbVie's Stock Sank in the First Half of 2019 Motley Fool
07:04AM  3 Dividend Stocks That Pay You More Than Exxon Does Motley Fool
Jul-03-19 05:50PM  Allergan (AGN) Gains But Lags Market: What You Should Know Zacks
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has a collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and gene therapy research collaboration with The National Institute for Bioprocessing Research and Training. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOMar 07Buy143.671,760252,858170,666Mar 07 03:19 PM
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM